Prospective study of anamorelin combined with physical activity and nutitrional counseling for cancer-related fatigue
Prof. Sriram Yennurajalingam
Cancer-related fatigue is the most frequent and debilitating symptom in patients with advanced cancer. Anamorelin is a ghrelin receptor agonist that can be administered orally. A prospective pilot study at MD Anderson Cancer Center (Houston, TX) found that anamorelin combined with physical activity and nutritional counseling resulted in improvement of cancer-related fatigue.
